776 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
BMY Bristol-Myers Squibb Company $61.3 $100.03B Uptrend
Article Searches
Bristol-Myers Squibb Co (BMY) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/04/25/bristol-myers-squibb-co-bmy-q1-2019-earnings-call.aspx?source=iedfolrf0000001 Apr 25, 2019 - BMY earnings call for the period ending March 31, 2019.
Bayer (BAYRY) Q1 Earnings Beat Estimates, Revenues Up Y/Y http://www.zacks.com/stock/news/403595/bayer-bayry-q1-earnings-beat-estimates-revenues-up-y-y?cid=CS-ZC-FT-403595 Apr 25, 2019 - Bayer (BAYRY) exceeds earnings estimates in the first quarter of 2019 and sales rise year over year.
Kidney-Cancer Market: Good for Patients, Hard for Investors https://www.fool.com/investing/2019/04/23/kidney-cancer-market-good-for-patients-hard-for-in.aspx?source=iedfolrf0000001 Apr 23, 2019 - Drugmakers battle for patients.
What's in Store for Celgene Corporation (CELG) Q1 Earnings? http://www.zacks.com/stock/news/391205/whats-in-store-for-celgene-corporation-celg-q1-earnings?cid=CS-ZC-FT-391205 Apr 23, 2019 - Investors are looking forward to Revlimid's performance and updates on the impending acquisition agreement with Bristol-Myers, when Celgene Corporation (CELG) reports Q1 results.
Are You Looking for a High-Growth Dividend Stock? Bristol-Myers Squibb (BMY) Could Be a Great Choice http://www.zacks.com/stock/news/390876/are-you-looking-for-a-high-growth-dividend-stock-bristol-myers-squibb-bmy-could-be-a-great-choice?cid=CS-ZC-FT-390876 Apr 23, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Bristol-Myers Squibb (BMY) have what it takes? Let's find out.
Top Gene-Sequencing Stocks for 2019 https://www.fool.com/investing/2019/04/19/top-gene-sequencing-stocks-for-2019.aspx?source=iedfolrf0000001 Apr 19, 2019 - These next-generation companies are working on game-changing ways to obtain and profit from genetic insight.
Bristol-Myers Squibb (BMY) Reports Next Week: Wall Street Expects Earnings Growth http://www.zacks.com/stock/news/386894/bristol-myers-squibb-bmy-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-386894 Apr 18, 2019 - Bristol-Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biotech Stock Roundup: GILD Collaborates on NASH, FCSC Surges on Deal http://www.zacks.com/stock/news/382518/biotech-stock-roundup-gild-collaborates-on-nash-fcsc-surges-on-deal?cid=CS-ZC-FT-382518 Apr 17, 2019 - Key highlights of the past week are collaborations and pipeline updates.
Why Celgene Shareholders Should Hold On to Their Bristol-Myers Squibb Stock Once the Acquisition Closes https://www.fool.com/investing/2019/04/16/why-celgene-shareholders-should-hold-on-to-their-b.aspx?source=iedfolrf0000001 Apr 16, 2019 - The fat lady is getting ready to sing with this big pharma deal. Celgene shareholders will soon have a decision to make.
Bristol-Myers' Shareholders Vote for Celgene Acquisition http://www.zacks.com/stock/news/381001/bristol-myers-shareholders-vote-for-celgene-acquisition?cid=CS-ZC-FT-381001 Apr 15, 2019 - Bristol-Myers' (BMY) gets a green signal from a majority of its shareholders for the merger with Celgene Corporation.

Pages: 12345678...78

<<<Page 3>